NIAID supports the study of global research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases and conditions. In addition to advancing these scientific goals, NIAID global research helps to improve the health of millions of people around the world, to protect the United States against infectious disease threats, and to promote international economic and political stability. Together, these efforts establish NIAID as a leader in global health.
NIH-Sponsored Clinical Trial of Chikungunya Vaccine Opens—Nov. 24, 2015
Media Availability: NIH-Funded Study Reveals Why Malaria Vaccine Only Partially Protected Children, Infants—Oct. 22, 2015
Media Availability: Immune Responses Provide Clues for HIV Vaccine Development—Oct. 21, 2015
Media Availability: HIV Cure Research: NIH Scientists Create Two-Headed Protein to Deplete HIV Reservoir—Oct. 20, 2015
All Global Research News Releases
News From NIAID-Supported Institutions
Last Updated November 24, 2015